Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin vs Permethrin for Scabies
NCT00262418Phase 2Completed
- Sponsor
- Ghent University
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivermectin in scabies (2 arms), sponsored by Ghent University. Primary endpoint: Clinical healing of the skin injuries at 28 days. Started Jul 2004; status: completed.
02
Drugs
ivermectin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT00262418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262418.